• Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study

    Tuesday December 7th 2021

  • Sequana Medical announces positive interim results of SAHARA DESERT, the alfapump DSR® study in heart failure patients with persistent congestion

    Tuesday December 7th 2021

  • New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster

    Monday December 6th 2021

  • Celyad Oncology announces $32.5 million private placement with Fortress Investment Group

    Monday December 6th 2021

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    Wednesday December 1st 2021

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    Wednesday December 1st 2021

  • Lonza and Bioqube Ventures sign a framework agreement for the future development and manufacture of biologics and small molecules for Bioqube’s portfolio companies

    Tuesday November 30th 2021

  • Your news here?

  • Confo Therapeutics enters collaborative agreement with Regeneron

    Tuesday November 30th 2021

  • Mayne Pharma and Mithra announce TGA approval of Nextstellis® oral contraceptive

    Monday November 29th 2021

  • Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

    Monday November 29th 2021


Strategic Partners